Remedios D, Saifuddin A, Pringle J
The Royal National Orthopaedic Hospital Trust and London Bone Tumour Service, Stanmore, Middlesex, UK.
J Bone Joint Surg Br. 1997 Jan;79(1):26-30. doi: 10.1302/0301-620x.79b1.7102.
We have reviewed 13 operations on 11 patients using curettage and polymethylmethacrylate cement for giant-cell tumour of bone (GCT) to assess the value of radiology in the early detection of recurrence. There were four recurrences, the most specific radiological sign on plain radiography was lysis of 5 mm or more at the cement-bone interface. This preceded clinical signs by a mean of four months and was identified at a mean of 3.75 months after operation. There was not always a complete sclerotic margin around the cement, but when it was present, there was never evidence of recurrence. MRI was helpful in assessing cases with evidence of recurrence. Frequent surveillance with plain radiography should continue for one year after operation irrespective of clinical signs of recurrence. When the appearance of the plain radiographs suggests recurrence, MRI should be performed and followed by image-guided needle biopsy.
我们回顾了11例患者接受的13例使用刮除术和聚甲基丙烯酸甲酯骨水泥治疗骨巨细胞瘤(GCT)的手术,以评估放射学在早期检测复发中的价值。有4例复发,平片上最具特异性的放射学征象是骨水泥-骨界面处5mm或更大范围的骨质溶解。这比临床症状提前平均4个月出现,且在术后平均3.75个月被发现。骨水泥周围并不总是有完整的硬化边缘,但当存在时,从未有复发的迹象。MRI有助于评估有复发证据的病例。无论有无复发的临床症状,术后均应持续进行平片频繁监测1年。当平片表现提示复发时,应进行MRI检查,随后进行影像引导下的穿刺活检。